Product Information
NYMYO 0.25-0.035 MG (28) TAB is a generic product labeled by Mayne Pharma, priced at $0.1293 per EA under NDC 51862064501. Its NADAC has been published 161 times since Oct 20, 2021.
Manufacturer
Mayne PharmaNDC
51862064501
Classification
Generic
Dosage Form
KIT
Last Updated
10/23/2024
Approval Type
Generic (ANDA)
FDA Application
ANDA090523On Market Since
10/11/2020
Price Statistics
The NADAC for NYMYO 0.25-0.035 MG (28) TAB has been published 161 times since Oct 20, 2021, and over the history we have for it it has declined 40.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1293 per EA |
|---|---|
| All-time high | $0.2176 (Nov 10, 2021) |
| All-time low | $0.1144 (Jul 17, 2024) |
| Median price | $0.1406 |
| Average price | $0.1459 |
| Largest weekly change | -20.3% (Dec 22, 2021) |
| Weeks tracked | 161 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NYMYO 0.25-0.035 MG (28) TAB?
The current National Average Drug Acquisition Cost (NADAC) for NYMYO 0.25-0.035 MG (28) TAB, manufactured by Mayne Pharma, is $0.1293 per EA (NDC 51862064501), effective Nov 13, 2024.
How has the price of NYMYO 0.25-0.035 MG (28) TAB changed over time?
Over the history we have for it, the NADAC for NYMYO 0.25-0.035 MG (28) TAB has declined 40.6%. It has been tracked across 161 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for NYMYO 0.25-0.035 MG (28) TAB?
Since Oct 20, 2021, the NADAC for NYMYO 0.25-0.035 MG (28) TAB has ranged from a low of $0.1144 (Jul 17, 2024) to a high of $0.2176 (Nov 10, 2021), with a median of $0.1406 per EA.
Are there cheaper alternatives to NYMYO 0.25-0.035 MG (28) TAB?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TRI-LO-ESTARYLLA TABLET, is $0.1049 per EA — about 19% below NYMYO 0.25-0.035 MG (28) TAB.
Who manufactures NYMYO 0.25-0.035 MG (28) TAB?
NYMYO 0.25-0.035 MG (28) TAB (NDC 51862064501) is labeled by Mayne Pharma, and CMS classifies it as a generic product.
Related Drugs
Same classification